a All SDS patients were genetically characterized by compound heterozygosity c.183_184TA>CT/c.258+2T>C. Patients did not receive G-CSF treatment and were not diagnosed with MDS or AML at the time of bone marrow sampling. All patients presented with pancreatic insufficiency (serum trypsinogen level <6 µg/L) and growth retardation (≤ 2 SD). All patients but SDS438 were neutropenic at sampling (absolute neutrophil counts, ANC < 1.5×10 9 /l); SDS438 had ANC = 1.62×10 9 /l).
b See Table S6 for further patient characteristics. Table S5 . Related to Figure 5 . In vitro exposure of HSPCs to S100A8/9 activates transcriptional signatures related to TLR signaling and cellular stress/apoptosis. 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Mice genotyping and sample collection DNA was extracted from mouse toes with DirectPCR Lysis Reagent (Viagen Biotech). Genotyping and Cre-mediated recombination were verified on genomic DNA samples using the primers listed in the table below. Mouse bone marrow and bone fraction cells were isolated as previously described (Raaijmakers et al., 2010) . Red blood cells (RBC) were lysed with ACK lysing buffer (Lonza) before surface markers staining. Peripheral blood was collected from the submandibular vein in K 2 EDTA-coated microtainers (BD) and analyzed using a Vet ABC counter (Scil Animal Care).
Genotyping primers used in the study.
Bone mineral density and 3-point bending test analysis
Cortical BMD was calculated from µCT cortical data on the basis of a calibration scanning obtained using two phantoms with known density (0.25 g/cm 3 and 0.75 g/cm 3 ; Bruker MicroCT) under identical conditions as for the femurs. For the bending test, femurs were placed in a custom-modified Single Column Lloyd LRX System bending device (Lloyd Instruments) and analyzed as previously reported (van der Eerden et al., 2013) using CtAnalyzer software (Bruker MicroCT).
Goldner's Masson trichrome staining
Femurs were embedded in methylmetacrylate as indicated before (Derkx et al., 1998) . Sections of 6 µm were deacrylated, hydrated and stained accordingly to the previously described protocol (Gruber, 1992) . Images of the metaphysial area were captured with a Nikon Eclipse E400 system (Nikon) using a 20X objective lens. Data was analyzed using Image J software (http://imagej.nih.gov/ij/). Briefly, the bone surface was manually selected and the perimeter length calculated. Osteoblasts were manually identified based on staining and morphology. The frequency of osteoblasts was calculated as percentage of osteoblast area in the bone surface and as number of osteoblasts per mm of bone.
CFU-F assay
Primary bone fraction cells were resuspended in growth medium, consistent of αMEM, 20% FBS (Life Technologies), and Penicillin-Streptomycin solution (Life Technologies), and cultured under hypoxic conditions (5% O 2 , 5% CO 2 ) in 24-well plates (seeding density: 6.5 x 10 4 cells/cm 2 ). After 24h, the medium was changed to eliminate non-adherent cells. Colonies were stained after 7 days of culture. Briefly, medium was removed and cells were fixed 5' in methanol, stained in a 1:20 dilution of Giemsa staining (Merck Millipore) in distilled water and rinsed with tap water. Colonies were counted with an Olympus CK2 inverted microscope, using a 10X magnification.
Primary cell isolation and flow cytometry
All FACS antibodies incubations were performed in PBS+0.5%FCS for 20 min on ice. To identify hematopoietic stem and progenitor cells (HSPCs), bone marrow cells were first co-stained with a cocktail of biotin-labelled antibodies against the following lineage ( All FACS events were recorded using a BD LSR II Flow Cytometer and analyzed with FlowJo 7.6.5 software (Tree Star). Cells were sorted with a BD FACSAria III.
SBDS mutation analysis
Mutations in SBDS were evaluated in the RNA sequencing data of SDS patients and healthy controls using the Integrative Genomics Viewer (IGV) (Robinson et al., 2011) . The c.183_184TA>CT mutation was quantified by annotating the number of reads presenting each of the four different nucleotides for both the positions 183 and 184. Because of its intronic position, the c.258+2T>C mutation was assessed by quantifying the usage of the 251-252 cryptic donor site (Boocock et al., 2003) . Specifically, we quantified the fraction of spliced reads with an 8-bp deletion (nucleotides 251-258) as an indication of the mutated genotype.
Mitochondrial membrane potential quantification
After staining cells for surface antigens, cells were washed in PBS+0.5%FBS and centrifuged. Cells were resuspended in PBS+0.5%FBS and tetramethylrhodamine methyl ester (TMRM, ThermoFisher Scientific) was added from a 50 mM stock solution in DMSO to a final non-quenching concentration of 100 nM. After incubation for 20 min at 37°C, cells were washed with PBS+0.5%FBS and analyzed. Cells treated with 1 µM p-trifluoromethoxy carbonyl cyanide phenyl hydrazone (FCCP) were used as positive control for membrane depolarization.
ROS detection
After surface antigen staining, cells washed in PBS+0.5%FBS and centrifuged. A stock solution of 2.5 µg/µl 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate acetyl ester (CM-H2DCFDA, Life Technologies) in DMSO was diluted with PBS+0.5%FBS to a final concentration of 3 ng/µl. Cells were resuspended with the CM-H2DCFDA solution and stained for 20 min at 37°C, washed in PBS+0.5%FBS and analyzed.
For dihydroethidium (DHE) studies, the compound (Sigma-Aldrich) was reconstituted to a 100 mM solution in DMSO. After surface antigen staining and washing, cells were resuspended in 500 µl of diluted DHE solution (1:100,000 in HBSS) and incubated at 37°C for 30 min, then washed in PBS+0.5%FBS and analyzed.
Cell cycle analysis
Mice labeled in vivo by BrdU were sacrificed and bone marrow cells were stained for surface antigen. BrdU staining was performed using the FITC BrdU Flow Kit (BD Biosciences) following the manufacturer's instructions.
For Ki67-based cell cycle analysis, cultured or freshly isolated cells were first stained for surface markers and then fixed and permeabilized with Cytofix/Cytoperm Fixation/Permeabilization Solution Kit (BD Biosciences). After washing, cells were incubated with FITC anti-Ki67 (B56, BD Biosciences) diluted in 1X Perm/Wash buffer (BD Biosciences) for 20 min and then washed. Cells were resuspended in PBS+0.5%FBS and 7AAD was added to detect DNA.
Alkaline comet assay
HSPCs were resuspended in 0.7% low melting agarose (Sigma-Aldrich) in PBS at a concentration of 10 5 cells/ml. 50 µl of cell suspension were spread on CometSlides (Trevigen) and the agarose was allowed to solidify for 30 min at 4°C. Slides were incubated for 1 h at 4°C in lysis buffer (1% Triton-X100 freshly added to 2.5M NaCl, 100 mM EDTA, 10 mM Tris/pH10 solution) protected from light and placed in an electrophoresis tray. After 20 min incubation in alkaline solution (200mM NaOH, 1mM EDTA, freshly prepared), unwound DNA was run in the same solution for 30 min at 1 V/cm. After electrophoresis, slides were washed twice in distilled water for 5 min, fixated in 70% ethanol for 5 min and allowed to dry at 37°C. DNA was stained for 5 min in SYBR Gold (Life Technologies), washed in distilled water and allowed to dry in the dark. Images were captured with a Leica DMRXA fluorescent microscope (10X magnification). DNA damage severity was manually quantified according to the score system depicted in Figure S3D .
Bone marrow transplantation
For serial (competitive) transplantation studies, bone marrow cells from OCS and BL6.SJL mice were isolated and RBC-depleted as described above. BL6.SJL cells were mixed in a 1:1 ratio with cells from OCS f/+ or OCS f/f mice. 9
week-old B6.SJL mice were lethally irradiated (8.5Gy) and transplanted with a total of 10 6 bone marrow cells.
For transplantation in S100A9Tg mice, donor bone marrow cells were isolated from 12-week old BL6.SJL mice and transplanted into lethally irradiated (8.5Gy) C57BL/6 or S100A9Tg mice (F10 backcross in C57BL76). Each mouse received 2x10 6 bone marrow cells by tail vein injection and was sacrificed one month after transplantation.
In all transplantation experiment, recipients received antibiotics in the drinking water for 2 weeks after transplantation.
S100A8/9 measurements
To quantify intracellular levels of S100A8/9 proteins, bone fraction cell suspensions were first stained for surface markers and next fixated and permeabilized with Cytofix/Cytoperm Fixation/Permeabilization Solution Kit (BD Biosciences) according to the manufacturer's instructions. Cells were then resuspended in 1X Perm/Wash buffer (BD Biosciences) and incubated for 20 min with polyclonal rabbit antibodies against mouse S100A8 or S100A9 (Vogl et al., 2014) . After washing, cells were incubated for 20 min with Pacific Orange-labelled goat anti-rabbit secondary antibody To analyze the concentration of S100A8/9 in the plasma, peripheral blood was collected in Microtainer PST tube (BD) and centrifuged to collect the plasma fraction. Samples were stored at -80°C until the moment of analysis. S100A8/9 was quantified by ELISA as previously described (Vogl et al., 2014) .
Immunohistochemical staining of low-risk MDS and age-matched controls (biopsies obtained for disease staging from lymphoma patients without evidence of intramedullary localization) were performed on 5 µm bone marrow sections, which were deparaffinized in xylene and hydrated in a graded series of alcohol. Antigen retrieval was achieved by microwave treatment in citrate buffer (10mM pH 6.0) and blocking of the endogenous peroxidases was performed with 3% H 2 O 2 in PBS. Sections were blocked using 10% normal human and goat serum (DAKO) in Teng-T solution followed by overnight incubation at 4°C with primary antibody anti-S100A8 and S100A9 (Vogl et al., 2014) diluted 1:500, CD271 (Sigma-Aldrich) diluted 1:200, or normal rabbit immunoglobulin (DAKO) diluted accordingly.
Immunoreactions were detected using biotinylated secondary antibody (goat anti-rabbit, 1:2000 dilution) with Vectastain ABC Elite Kit (Vector Laboratories) and 3,3'-diaminobenzidine tetrahydrochloride (Sigma-Aldrich). For all stainings, nuclei were counterstained with haematoxylin (Vector Laboratories). Images of the stained tissue were acquired using a Leica DM5500B upright microscope with 40x lenses and LAS-AF image acquisition software.
Sbds-knockdown and expression analysis in OP9 cells
OP9 cells were grown in DMEM+10%FBS+1%PenStrep. Sbds RNA interference was achieved by lentiviral transduction. Briefly, short hairpin RNAs against Sbds (shSbds1:TRCN0000108586; and shSbds4:TRCN0000316346) and a commercial non-target control (shControl: SHC002 [SHC]), cloned in the pLKO.1 backbones, were selected from the Mission TRC shRNA library (Sigma-Aldrich). Lentiviral shRNAs were produced in HEK293T cells after cotransfection of shControl, shSbds1, or shSbds4 together with the packaging plasmids pSPAX2 and pMDG.2. OP9 cells were infected with lentivirus for 72 hours in the presence of 4 µg/mL polybrene and selected 72 hours with 2 µg/mL puromycin.
RNA isolation, conversion to cDNA and qPCR were performed accordingly to previously described methods (Zambetti et al., 2015) , using the SuperScript II Reverse Transcriptase (Thermo Fisher Scientific) for conversion to cDNA. For qPCR, expression levels were obtained using the ddCt method using GAPDH as internal control and shControl sample as calibrator. For protein analysis, cells were lysed in Carin lysis buffer (20 mM Tris-HCl pH 8.0, 138 mM NaCl, 10mM EDTA, 100 mM NaF, 1% NP-40, 10% glycerol, 2mM sodium vanadate) supplemented with 0.5 mM DTT and the protease inhibitor SigmaFast (Sigma-Aldrich). 32 µg of protein per condition were denatured and separated on a Novex NuPage 4-12% Bis-Tris Gradient gel (Life Technologies) and transferred to Protran BA83 blotting paper (GE Healthcare Sciences). After blocking, membranes were incubated overnight at 4°C with the following primary antibodies: goat polyclonal anti-SBDS (Santa Cruz, S-15, 1:200); rabbit polyclonal anti-p53 (Leica, CM5, 1:2000) . Beta-actin was used as a loading control (mouse monoclonal anti-beta-actin, clone AC-15, Sigma-Aldrich, 1:10,000 dilution). After washing, blots were incubated with the following secondary antibody: IRDye 800CW Donkey anti-Goat IgG (H + L), IRDye® 800CW Donkey anti-Rabbit IgG (H + L), and IRDye 800CW Donkey anti-mouse IgG (H + L) (all from Li-COR and diluted 1:10,000). After final washing steps, Western blots were scanned and processed using an Odyssey Infrared Imager (Li-COR Biosciences).
HSPCs in vitro culture, S100A8/9 exposure and CFU-C assay LKS and Lin -c-Kit + Sca-1 -cells were sorted from wild type C57BL/6 mice and cultured in a serum-free medium, with the following composition: X-Vivo 15 (Lonza), 1% detoxified BSA, 50 µM β-mercaptoethanol (Life Technologies), 1:100 GlutaMAX™ Supplement (Life Technologies), 20 ng/ml recombinant murine SCF (Peprotech), 100 ng/ml recombinant murine Flt3-Ligand (Peprotech), 1:100 penicillin-streptomycin mixture (Life Technologies). The medium was supplemented with recombinant murine S100A8/9, produced with the same methods described earlier (Vogl et al., 2006) , at a final, clinically relevant concentration of 25-50 µg/ml, in the range of concentrations measured in the bone marrow supernatants of MDS patients (List, 2014) . A heat-inactivated control was obtained by incubating S100A8/9 at 80°C for 30 min; the protein was cooled-down and next added to the HSPC medium with the same concentration and volume as S100A8/9. LKS and Lin -c-Kit + Sca-1 -cells were cultured in 96-well plates at a cell density of 2.5x10 4 cells/well.
For human studies, cryopreserved CD34 + cells were used, which were isolated from cord blood obtained under informed consent by Ficoll gradient and MACS separation (Miltenyi Biotec). Thawed cells were resuspended in StemSpan SFEM II (STEMCELL Technologies) and recombinant human S100A8/9 was added (R&D systems) at a final concentration of 50 µg/ml. For the control medium, an equal volume of vehicle (PBS) was added. Cells were seeded in flat bottom 96 well-plates (5x10 4 cells/well).
For both mouse and human studies, cells were harvested at 4h for γH2AX and cell cycle studies and at 24 h for apoptosis assay.
To assess the effect of S100A9 on HSPC function, CD34 + cord blood cells were resuspended in SFEM1 medium
